US Patent 7803813 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists

Patent 7803813 was granted and assigned to Eli Lilly and Company on September, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78038130

Patent Inventor Names

Dana Rae Benesh0

Maria-Jesus Blanco-Pillado0

Date of Patent

September 28, 2010

Patent Application Number

118103880

Date Filed

June 4, 2007

Patent Citations Received

‌

US Patent 12071423 Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate

Patent Primary Examiner

‌

Janet L. Andres

Patent abstract

The present invention relates to compounds of formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7803813 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API